Stem cell research as innovation: Expanding the ethical and policy conversation

Journal of Law, Medicine and Ethics

Volumn 38, Issue 2, 2010, Pages 332-341

  Dresser, Rebecca ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CONFLICT; EMBRYO RESEARCH; EMBRYONIC STEM CELL; ETHICS; FINANCIAL MANAGEMENT; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; INTERPERSONAL COMMUNICATION; MASS COMMUNICATION; NATIONAL HEALTH ORGANIZATION; POLITICS; RESOURCE ALLOCATION; SCIENCE; SOCIAL BEHAVIOR; SOCIAL JUSTICE; THERAPEUTIC MISCONCEPTION; UNITED STATES;

ATTITUDE TO HEALTH; DIFFUSION OF INNOVATION; DISSENT AND DISPUTES; EMBRYO RESEARCH; EMBRYONIC STEM CELLS; HEALTH POLICY; HEALTH PRIORITIES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LOBBYING; NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH SUPPORT AS TOPIC; RESOURCE ALLOCATION; SCIENCE; SOCIAL JUSTICE; SOCIAL RESPONSIBILITY; THERAPEUTIC MISCONCEPTION; TRUTH DISCLOSURE; UNITED STATES;

EID: 77954950124     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2010.00492.x     Document Type: Conference Paper

References (33)

1. Weiss R. " Stem Cell Bill Easily Clears Senate but Lacks Votes to Override a Veto,": Washington Post. April 12, 2007, See for example, S. Smith, W. Neaves, and S. Teitelbaum, " Adult Stem Cell Treatments for Diseases?" 313, no. 5786 (2006): 439; M. Enserink, " Selling the Stem Cell Dream," 313, no. 5784 (2006): 160-163; A. Applebaum, " Stem Cell Stumping," , August 4, 2004
2. Couzin J. " Celebration and Concern over U.S. Trial of Embryonic Stem Cells," Science 2009, 323(no. 5914):568.
3. Vogel G. " Ready or Not? Human ES Cells Head Toward the Clinic," Science 2005, 308(no. 5728):1534-1538.
4. Normile D, Vogel G, Couzin J. " South Korean Team's Remaining Human Stem Cell Claims Demolished," Science 2006, 311(no. 5758):156-157. See
5. Solter D. " Politically Correct Human Embryonic Stem Cells?" New England Journal of Medicine 2006, 354(no. 11):1209.
6. " Stem Cell Basics," April 28, 2009, http://stemcells.nih.gov/info/basics/defaultpage, National Institutes of Health, , last visited March 11, 2010
7. See National Institutes of Health, note 6, at 17. See also B. Demick, " Hopes Founder on 'Big Lie,'" , January 9, 2006.
8. Martin T J. " Reactions to the Hwang Scandal," Science 2006, 311(no. 5761):607. J. Couzin, " ... And How the Problems Eluded Peer Reviewers," 311, no. 5757 (2006): 23-24
9. Holden C. " Battle Heats Up Over Cloning," Science 2002, 295(no. 5552):2009.
10. Gramling C. " Random Samples: People," Science 2005, 309(no. 5742):1937. R. L. Paarlberg, " The Great Stem Cell Race," (May-June 2005): 44-51
11. Holden C. " States, Foundations Lead the Way After Bush Vetoes Stem Cell Bill," Science 2006, 313(no. 5786):420-421. See, R. Paarlberg, " The Great Stem Cell Race," at 49-51
12. Okie S. " Stem-Cell Politics," New England Journal of Medicine 2006, 355(no. 16):1633-1637.
13. " Kerry's Acceptance: 'We Have It in Our Power to Change the World Again," ', July 30, 2004; " Ron Reagan's Speech to the Democratic National Convention," , July 27, 2004; Editorial, " Better to be Talked About ...," 431, no. 7006 (2004): 229
14. " Stem Cell Politics,": Washington Post. January 13, 2006, Editorial, C. Connolly, " Waging the Battle for Stem Cell Research," , June 9, 2002
15. http://www.medicalnewstoday.com/printerfriendlynews.php?newsid=122493, See " Stem Cell Research Advocates Concerned McCain Will Backtrack on Support If Elected President," September 23, 2008,, last visited March 11, 2010
16. Holden C. " Scientists Look to Missouri to Show the Way for Stem Cells," Science 2006, 314(no. 5800):737-738. See, M. Franck, " Stem Cell Fight Shatters Spending Records," (October 17, 2006); J. Mannies, " Talent, McCaskill Put Contrasts on Display During Debate," (October 11, 2006); Citizens for Barbara Fraser for County Council, " Fresh Idea #1: St. Louis County Will Benefit from Stem Cell Research," Campaign Brochure (2006).
17. Sulmasy D P. " Deliberative Democracy and Stem Cell Research in New York State: The Good, the Bad, and the Ugly," Kennedy Institute of Ethics Journal 2009, 19(no. 1):63-78.
18. Malakoff D. " The Calculus of Making Stem Cells a Campaign Issue," Science 2004, 305(no. 5685):760. See
19. Kiatpongsan S, Sipp D. " Monitoring and Regulating Offshore Stem Cell Clinics," Science 2009, 323(no. 5921):1564-1565. See, e.g., D. Shaywitz, " Stem Cell Hype and Hope," , January 12, 2006
20. Wilson J M. " A History Lesson for Stem Cells," Science 2009, 324(no. 5928):727-728.
21. Wade N. " Rethink Stem Cells? Science Already Has,": New York Times. March 10, 2009, See, e.g.
22. See Wilson, note 20, at 728 (describing media coverage of the clinical trial).
23. Harris G. " Pick to Lead Health Agency Draws Praise and Some Concern,": New York Times. July 9, 2009
24. Wade N. " Some Scientists See Shift in Stem Cell Hopes,": New York Times. August 14, 2006, R. Weiss, " Harvard Announces Private Project to Make Human Stem Cells," , June 7, 2006
25. http://report.nih.gov/rcdc/categories/PFSummaryTable.aspx, Working Group on Setting Research Priorities, , NIH Publication No. 97-4265 (1997): at 8-9. Stem cell research, like a substantial percentage of the studies NIH funds, comes under the heading of basic science. Basic science studies investigate problems in biology potentially relevant to many health conditions. But in response to pressure from Congress and advocacy organizations concerned about funding allocation, NIH requires researchers submitting basic science study proposals to describe the specific health applications of their work. Officials use this information to produce annual estimates of the support it gives to research on different medical conditions. These estimates have limited utility, however, because they combine general research categories, such as stem cell research, with specific disease categories, such as Alzheimer's disease. In addition, funded projects may be listed in more than one category. Critics say that the loose categorization system functions to give NIH officials substantial discretion over where the money actually goes. For estimates covering fiscal years 2005-2010, see " Estimates of Funding for Various Research, Condition, and Disease Categories," January 15, 2009,, last visited March 12, 2010
26. Dresser R. " Private-Sector Research Ethics: Marketing or Good Conflicts Management?" Theoretical Medicine and Bioethics 2006, 27(no. 2):115-39. See
27. Hegde D, Mowery D. " Politics and Funding in the U.S. Public Biomedical R&D System," Science 2008, 322(no. 5909):1797-1798. See, I address these issues in depth in R. Dresser, (Oxford University Press, 2001). See also D. Callahan, (University of California Press, 2003). For an analysis and critique of NIH priority setting, see Institute of Medicine, (Washington, D.C.: National Academy Press, 1998)
28. Gostin L. " Why Rich Countries Should Care about the World's Least Healthy People," JAMA 2007, 298(no. 1):89-91. See generally
29. Hall S. Merchants of Immortality: Chasing the Dream of Human Life Extension 2003, New York, Houghton Mifflin, N. Wade, " Apostle of Regenerative Medicine Foresees Longer Health and Life," , December 18, 2001
30. Callahan. supra note 28, at 32. 73-84. See, 232, 266, 275
31. Faden R. " Public Stem Cell Banks: Considerations of Justice in Stem Cell Research and Therapy," Hastings Center Report 2003, 33(no. 6):13-27. note 2
32. Shannon T. " From the Micro to the Macro," The Human Embryonic Stem Cell Debate 2001, 177-84. Holland SLebacqz KZoloth L. See, Cambridge, MIT Press